WNT5B and breast cancer: Of note, WNT5b was revealed to be a key regulatory factor that governs the phenotype of basal-like BC by activating canonical and non-canonical Wnt signalling, and in turn, its overexpression represents a specific marker of basal-like BC with the worst outcome [60].